Shenzhen has adopted a Biotech Industry Development Plan (2009-2015) that includes a commitment to invest 500 million RMB ($73.5 million) annually for the seven-year duration of the plan. The goal is to make Shenzhen a leading biotechnology center. The specific goals for the plan include helping to build three major biotech companies whose revenues will total more than 10 billion RMB ($1.5 billion), and developing five innovative drugs with worldwide patents. More details...